会计 来源:互联网 时间:2023-04-28 13:02:45
(资料图片)
1月4日,迈威生物宣布其自主研发的9MW3011注射液的临床试验申请正式获得国家药品监督管理局批准,针对β-地中海贫血患者铁过载相关适应症、真性红细胞增多症开展临床试验。目前,相关适应症领域尚无成熟有效的大分子治疗药物,因此,9MW3011有望在未来获得孤儿药资格,并成为全球范围内首个调节体内铁稳态的大分子药物。
标签:
上一篇:全球通讯!群益证券:给予山西汾酒增持评级,目标价位320.0元
下一篇:最后一页
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
22-09-30
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-28
23-04-27